Gilead Sciences
Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.
GILD Key Statistics
Stock Snapshot
With a market cap of 178.18B, Gilead Sciences(GILD) trades at $143.58. The stock has a price-to-earnings ratio of -54.10 and currently yields dividends of 2.24%.
As of 2026-09-13, Gilead Sciences(GILD) stock has fluctuated between $143.42 and $145.99. The current price stands at $143.58, placing the stock +0.1% above today's low and -1.7% off the high.
Gilead Sciences(GILD) shares are trading with a volume of 4.2M, against a daily average of 5.19M.
During the past year, Gilead Sciences(GILD) stock moved between $108.46 at its lowest and $157.29 at its peak.
During the past year, Gilead Sciences(GILD) stock moved between $108.46 at its lowest and $157.29 at its peak.
GILD News
...
Assembly Biosciences (ASMB) announced it has exercised its option to share 40% of the development costs and profits in the United States for its herpes simplex...
Analyst ratings
77%
of 30 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.